Xlife Sciences AG
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Xlife Sciences AG is a Swiss company that operates as a life sciences incubator and accelerator. It focuses on the value development and commercialization of promising, early-stage research projects sourced from universities and other research institutions. The company's mission is to bridge the gap between academic research and healthcare markets by advancing solutions for high unmet medical needs. Xlife Sciences concentrates its investments and development efforts across four key pillars: technology platforms, biotechnologies/therapies, medical technology (healthtech), and the application of artificial intelligence in digital health.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Xlife Sciences AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-17 07:00 |
Registration Form
Xlife Sciences AGs Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward …
|
English | 12.6 KB | |
| 2025-07-17 02:00 |
M&A Activity
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward…
|
English | 15.5 KB | |
| 2025-07-17 02:00 |
Registration Form
Portfoliounternehmen der Xlife Sciences AG, VERAXA Biotech AG, erreicht wichtig…
|
German | 16.4 KB | |
| 2025-06-24 18:00 |
Post-Annual General Meeting Information
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
|
English | 6.1 KB | |
| 2025-06-24 02:00 |
Post-Annual General Meeting Information
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
|
English | 8.2 KB | |
| 2025-06-24 02:00 |
Post-Annual General Meeting Information
Xlife Sciences AG: Erfolgreiche Generalversammlung und Wachstumsaussichten in 2…
|
German | 8.5 KB | |
| 2025-06-16 16:00 |
Regulatory News Service
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and Onc…
|
English | 9.8 KB | |
| 2025-06-16 02:00 |
Regulatory News Service
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and Onc…
|
English | 12.3 KB | |
| 2025-06-16 02:00 |
M&A Activity
Strategische Zusammenarbeit zwischen Xlife Sciences AG, Huraypositive Corp. und…
|
German | 13.4 KB | |
| 2025-06-13 17:42 |
M&A Activity
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Acc…
|
English | 9.0 KB | |
| 2025-06-13 02:00 |
M&A Activity
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Acc…
|
English | 11.4 KB | |
| 2025-06-13 02:00 |
Regulatory News Service
Strategische Allianz zwischen Xlife Sciences AG, JIPYONG LLC und JIPYONG IP sol…
|
German | 12.9 KB | |
| 2025-05-07 07:00 |
Environmental & Social Information
Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company F…
|
English | 9.9 KB | |
| 2025-05-05 07:00 |
Report Publication Announcement
Xlife Sciences AG confirms sustainable value development and strategic scaling …
|
English | 5.4 KB | |
| 2025-04-25 07:00 |
Annual Report
Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technologi…
|
English | 7.2 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-01-24 | Grace Beteiligungs GmbH | Close relation | Buy | None | 57,537.30 EUR |
| 2022-01-24 | Pfleger, Christian | Board | Buy | None | 36,800.00 EUR |
| 2022-01-24 | Wild, Daniel | Supervisory board | Buy | None | 5,658.16 EUR |
| 2022-01-24 | Pfleger, Christian | Board | Buy | None | 18,480.00 EUR |
| 2022-01-22 | Horch, Johann | Board | Buy | None | 1,210.61 EUR |
| 2022-01-21 | Baumann, Oliver R. | Board | Buy | None | 21,500.00 EUR |
| 2022-01-19 | Baumann, Oliver R. | Board | Buy | None | 27,000.00 EUR |
| 2022-01-14 | Baumann, Oliver R. | Board | Buy | None | 22,935.20 EUR |
| 2021-12-20 | Baumann, Oliver R. | Board | Buy | None | 13,625.00 EUR |
| 2021-12-17 | Engels Consulting & Investment GmbH | Close relation | Sell | None | 22,500.00 EUR |
